COMPOUNDS AND COMPOSITIONS AS C-KIT KINASE INHIBITORS

The invention provides compounds of formulae (I) and (II) and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some e...

Full description

Saved in:
Bibliographic Details
Main Authors LOREN, JON, NGUYEN, BAO, LI, XIAOLIN, LIU, XIAODONG, PETRASSI, HANK MICHAEL JAMES, NABAKKA, JULIET, YEH, VINCE, MOLTENI, VALENTINA
Format Patent
LanguageEnglish
French
German
Published 09.07.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention provides compounds of formulae (I) and (II) and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of c-kit or c-kit and PDGFR (PDGFRα, PDGFR ) kinases.
AbstractList The invention provides compounds of formulae (I) and (II) and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of c-kit or c-kit and PDGFR (PDGFRα, PDGFR ) kinases.
Author LIU, XIAODONG
LOREN, JON
NGUYEN, BAO
YEH, VINCE
PETRASSI, HANK MICHAEL JAMES
MOLTENI, VALENTINA
LI, XIAOLIN
NABAKKA, JULIET
Author_xml – fullname: LOREN, JON
– fullname: NGUYEN, BAO
– fullname: LI, XIAOLIN
– fullname: LIU, XIAODONG
– fullname: PETRASSI, HANK MICHAEL JAMES
– fullname: NABAKKA, JULIET
– fullname: YEH, VINCE
– fullname: MOLTENI, VALENTINA
BookMark eNrjYmDJy89L5WQwdfb3DfAP9XMJVnD0c1EA84I9Qzz9_YACwQrOut6eIQrenn6Owa4Knn4enk6eIf5BwTwMrGmJOcWpvFCam0HBzTXE2UM3tSA_PrW4IDE5NS-1JN41wMjc1NDQwNjR0JgIJQCi0Cj8
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate VERBINDUNGEN UND ZUSAMMENSETZUNGEN ALS C-KIT-KINASEHEMMER
COMPOSÉS ET COMPOSITIONS POUVANT ÊTRE UTILISÉS EN TANT QU'INHIBITEURS DE LA KINASE C-KIT
ExternalDocumentID EP2751103A1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP2751103A13
IEDL.DBID EVB
IngestDate Fri Jul 19 15:56:44 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP2751103A13
Notes Application Number: EP20120756884
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140709&DB=EPODOC&CC=EP&NR=2751103A1
ParticipantIDs epo_espacenet_EP2751103A1
PublicationCentury 2000
PublicationDate 20140709
PublicationDateYYYYMMDD 2014-07-09
PublicationDate_xml – month: 07
  year: 2014
  text: 20140709
  day: 09
PublicationDecade 2010
PublicationYear 2014
RelatedCompanies IRM LLC
RelatedCompanies_xml – name: IRM LLC
Score 2.9373126
Snippet The invention provides compounds of formulae (I) and (II) and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title COMPOUNDS AND COMPOSITIONS AS C-KIT KINASE INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140709&DB=EPODOC&locale=&CC=EP&NR=2751103A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LTsMwzJoGAm4wQIyXckC9Vaz0tRwq1KatWlAfWju029SntEs3bUX8Pm7UDS5wcxLJiS05tuNHAJ4KVLlSpWhioedUVKo6E_NakkSNlqpcF1O0oruIbhBq3lx5W6iLAaz2tTC8T-gXb46IElWgvLf8vt78PGLZPLdy95yvcGr96qaGLfTeMXoL-oQKtmU4cWRHTGAMISGcGS86WhYT2URH6aizors2-86H1RWlbH5rFPccjmNE1rQXMKiaEZyy_cdrIzgJ-ng3gr3o7S5BZVEQR_PQTogZ2oSPEp8XARMzIUx891OCvriZOMQPPd_y02iWXAFxnZR5Iu6_PNC6dOLDSeVrGDbrproBUtCpVsqanHX9sVQ5o0gARdOC5iXyuMrHMP4Tze0_a3dw1jGNp5_Sexi228_qAZVsmz9y9nwDUEB7Xg
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLamgRg3GCDGMwfUW8VGX8uhQm3aqmXrQ2uHdpvWl7RLN7Ei_j5u1A0ucMtDchJLju3Y_gLwlKHKHRWyKmZaSkW5KFdiWo5GokpzRSqzMVrRTUTXD1R3Lr8tlEUH1vtaGI4T-sXBEVGiMpT3mt_X259HLIvnVu6e0zUObV6dRLeE1jtGb0EbUsEydTsKrZAJjGFLCGb6i4aWxVAy0FE60hpw3sZyejebopTtb43inMFxhMSq-hw6RdWHHtt_vNaHE7-Nd2OzFb3dBSgs9KNwHlgxMQKL8F7s8SJgYsSEiRMvIeiLG7FNvMD1TC8JZ_ElEMdOmCvi-svDWZd2dNipdAXdalMV10AyOlZzSZVWDT6WIq2oQmWKpgVNc-RxkQ5g8CeZm3_mHqHnJv50OfWCyS2cNgzkqaj0Drr1x2dxjwq3Th84q74BPSB-Sw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMPOUNDS+AND+COMPOSITIONS+AS+C-KIT+KINASE+INHIBITORS&rft.inventor=LOREN%2C+JON&rft.inventor=NGUYEN%2C+BAO&rft.inventor=LI%2C+XIAOLIN&rft.inventor=LIU%2C+XIAODONG&rft.inventor=PETRASSI%2C+HANK+MICHAEL+JAMES&rft.inventor=NABAKKA%2C+JULIET&rft.inventor=YEH%2C+VINCE&rft.inventor=MOLTENI%2C+VALENTINA&rft.date=2014-07-09&rft.externalDBID=A1&rft.externalDocID=EP2751103A1